Multimodal molecular encapsulation of nicardipine hydrochloride by β-cyclodextrin, hydroxypropyl-β-cyclodextrin and triacetyl-β-cyclodextrin in solution.: Structural studies by 1H NMR and ROESY experiments

被引:105
作者
Fernandes, CM
Carvalho, RA
da Costa, SP
Veiga, FJB [1 ]
机构
[1] Univ Coimbra, Fac Pharm, Pharmaceut Technol Lab, P-3000 Coimbra, Portugal
[2] Univ Coimbra, Fac Sci & Technol, Dept Biochem, Coimbra, Portugal
关键词
nicardipine; cyclodextrins; inclusion complexes; H-1; NMR; ROESY;
D O I
10.1016/S0928-0987(03)00025-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Proton nuclear magnetic resonance spectroscopy (H-1 NMR), which has become an important tool for in vitro study of cyclodextrin (CD) complexes, was used to study and structurally characterize the inclusion compounds formed in solution between nicardipine hydrochloride (NC) and beta-cyclodextrin (betaCD), hydroxypropyl-beta-cyclodextrin (HPbetaCD) and triacetyl-beta-cyclodextrin (TAbetaCD). The large variation of chemical shifts from protons located around the interior of the hydrophobic cavity (i.e. H-3, H-5 and H-6) coupled with minimal variation of shifts from protons located on the outer sphere of the betaCD (i.e. H-1, H-2 and H-4) provided clear evidence of inclusion complexation. In the presence of the different CDs, the aromatic protons of NC were the most affected, suggesting a strong involvement of the phenyl groups in the inclusion mechanism. The application of continuous variation method indicated the presence of complexes with a 1:1 host/guest stoichiometry for all the studied CDs. Two-dimensional rotating frame nuclear Overhauser effect spectroscopy (ROESY) experiments were carried out to further support the proposed inclusion mode. Inspection of the ROESY spectra allowed the establishment of spatial proximities between several aromatic hydrogens of the guest and the CD protons, indicating that the inclusion occurs by accommodation of the two aromatic groups of NC. All the experimental data were further rationalized to elaborate possible three-dimensional geometric models of inclusion complexes. From the aforementioned observations, we concluded there is no preference for inclusion of a particular aromatic ring. Instead, two types of 1:1 complexes with different inclusion structures may exist simultaneously in solution, being alternatively included through the wider side of the cavity, i.e. the so-called multimodal inclusion occurs in the interaction of NC with the different CDs. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:285 / 296
页数:12
相关论文
共 31 条
[1]   Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-β-cyclodextrin in aqueous solution:: Isothermal titration microcalorimetry, 13C NMR spectrometry, and molecular dynamics simulation [J].
Aki, H ;
Niiya, T ;
Iwase, Y ;
Yamamoto, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (08) :1186-1197
[2]  
Amato ME, 1998, MAGN RESON CHEM, V36, P693
[3]   STRUCTURE DETERMINATION OF A TETRASACCHARIDE - TRANSIENT NUCLEAR OVERHAUSER EFFECTS IN THE ROTATING FRAME [J].
BOTHNERBY, AA ;
STEPHENS, RL ;
LEE, JM ;
WARREN, CD ;
JEANLOZ, RW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1984, 106 (03) :811-813
[4]   The stability of cyclodextrin complexes in solution [J].
Connors, KA .
CHEMICAL REVIEWS, 1997, 97 (05) :1325-1357
[5]   HIGH-FIELD NUCLEAR-MAGNETIC-RESONANCE TECHNIQUES FOR THE INVESTIGATION OF A BETA-CYCLODEXTRIN-INDOMETHACIN INCLUSION COMPLEX [J].
DJEDAINI, F ;
LIN, SZ ;
PERLY, B ;
WOUESSIDJEWE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (07) :643-646
[6]  
DJEDAINI F, 1991, NEW TRENDS CYCLODEXT, P215
[7]  
Fathy M, 2000, PHARMAZIE, V55, P513
[8]   Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds [J].
Fernandes, CM ;
Vieira, MT ;
Veiga, FJB .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 15 (01) :79-88
[9]  
Forgo P, 1998, CARBOHYD RES, V306, P473
[10]   A PROTON NUCLEAR-MAGNETIC-RESONANCE STUDY OF THE INCLUSION COMPLEX OF NAPROXEN WITH BETA-CYCLODEXTRIN [J].
GANZAGONZALEZ, A ;
VILAJATO, JL ;
ANGUIANOIGEA, S ;
OTEROESPINAR, FJ ;
BLANCOMENDEZ, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 106 (03) :179-185